Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARS1 | P56192 | 6/20 | 0.44 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108560 | 1.00 | MARS1 (0.44) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| SCHEMBL108559 | 1.00 | MARS1 (0.44) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL9081566 | 0.98 | MARS1 (0.43) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL3089952 | 0.98 | MARS1 (0.43) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL200899 | 0.98 | MARS1 (0.43) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| Hydrogen Sulfide SCHEMBL9171273 | 0.98 | MARS1 (0.43) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL200898 | 0.98 | MARS1 (0.43) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| Sulfur Dioxide SCHEMBL28722439 | 0.96 | MARS1 (0.42) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| SCHEMBL6552211 | 0.94 | MARS1 (0.41) | MARS1METAP2METAP1ALDH1A1L3MBTL1 | |
| SCHEMBL28363177 | 0.93 | ALDH1A1 (0.41) | MARS1METAP2METAP1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113527399-B | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-113527399-A | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-118221675-A | Electron transport material, preparation method and application thereof, solar cell and preparation method thereof | 天合光能股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-110707221-B | Application of amino acid ionic liquid in preparation of perovskite layer in perovskite photoelectric device | 北京大学深圳研究生院 | 2023-09-01 | — | — | CN | disclosed |
| CN-115043765-B | Preparation of methionine derivative and its salt and use as gene carrier | 黑龙江八一农垦大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-113527399-B | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115043765-A | Preparation of methionine derivative and salt thereof and application of methionine derivative and salt thereof as gene vector | 黑龙江八一农垦大学 | 2022-09-13 | — | — | CN | disclosed |
| EP-3596052-B1 | CHEMICAL COMPOUNDS | NODTHERA LTD (GB) | 2022-07-20 | — | — | EP | disclosed |
| US-11345669-B2 | Urea derivatives and methods of use thereof | NodThera Limited (GB) | 2022-05-31 | — | — | US | disclosed |
| US-11345669-B2 | Urea derivatives and methods of use thereof | NodThera Limited (GB) | 2022-05-31 | — | — | US | disclosed |
| CN-113527399-A | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2021-10-22 | — | — | CN | disclosed |
| EP-0873123-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1998-10-28 | — | — | EP | disclosed |
| WO-1998032741-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 1998-07-30 | — | — | WO | disclosed |
| WO-1997017070-A1 | INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES | UNIVERSITY OF PITTSBURGH (US) | 1997-05-15 | — | — | WO | disclosed |
| EP-0126974-B1 | CARBOXYALKYL PEPTIDE DERIVATIVES | G.D. Searle & Co. (US) | 1988-06-15 | — | — | EP | disclosed |
| US-4568666-A | COLLAGENASE INHIBITORS, ANTIARTJRITIC AGENTS | G. D. SEARLE & CO. (US) | 1986-02-04 | — | — | US | disclosed |
| US-4511504-A | COLLAGENASE INHIBITORS | G.D. SEARLE & CO. (US) | 1985-04-16 | — | — | US | disclosed |
| EP-0126974-A1 | Carboxyalkyl peptide derivatives | G.D. Searle & Co. (US) | 1984-12-05 | — | — | EP | disclosed |
| EP-0038046-B1 | PHARMACEUTICAL AMIDES, AND PREPARATION, FORMULATIONS AND USE THEREOF | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-02-29 | — | — | EP | disclosed |
| EP-0038046-A2 | Pharmaceutical amides, and preparation, formulations and use thereof | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345669-B2 | Urea derivatives and methods of use thereof | IL1B, IL1A, NOD1 | MARS1 1374/4885METAP2 1644/4885METAP1 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.